January 4, 2012 - A study reported in the current issue of Pediatric and Developmental Pathology compares cardiac tissue from 12 patients with histiocytoid cardiomyopathy (HC) and 12 age-matched controls. Researchers found differences in gene expression that could indicate a predisposition for HC.

January 4, 2012 – ECRI, an independent nonprofit that researches the best approaches to improving patient care, listed 10 health technology issues that hospital leaders should have on their watch lists for 2012. The list takes into account critical patient safety, as well as economic and regulatory pressures currently facing healthcare executives.

January 3, 2012 — Independent research firm KLAS has named Hitachi’s Oasis High-field Open MRI (magnetic resonance imaging) as the Open category leader for the second consecutive year in its “Top 20 Best in KLAS Awards” report. KLAS presented this award to Hitachi Medical Systems America at an RSNA 2011 reception on Nov. 27, 2011.

January 3, 2012— In 2011, Hitachi Medical Corp. acquired Aloka Company and formed Hitachi Aloka Medical. The new company exhibited its expanded line of ultrasound products in Hitachi’s booth at RSNA 2011.

January 3, 2012 – Siemens Healthcare recently announced the winners of its 2011 International CT [computed tomography] Image Contest. More than 160 institutes and hospitals from 43 countries on all continents submitted more than 600 CT images –– all captured on Siemens CT scanners using the lowest possible radiation dose. Selected by an international jury of experts, the seven winners –– which were displayed at RSNA 2011 –– hail from China, England, France, Ireland, Macau, Singapore and the United States. In addition to exhibiting a high standard of quality, the images are impressive examples of how valuable diagnostic information can be obtained even at an extremely low dose.

 

January 3, 2012 – Ikaria Inc. announced it commenced its global development program, the PRESERVATION I clinical trial, for its Bioabsorbable Cardiac Matrix (BCM). The CE mark registration trial has commenced in Australia, and will be followed in Europe.  The trial also is expected to commence in other countries, including Israel. 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now